How a community center launches CAR T and bispecific care: managing CRS/ICANS outpatient, closing access gaps, adapting to REMS.
Andrew Dalovisio, MD
Advertisement
Articles by Andrew Dalovisio, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Taletrectinib Sustains Durable ROS1+ NSCLC Responses at 3-Year Follow-Up
2
A Look Inside CONVERGE: Intratumoral Therapy Comes to Locally Advanced NSCLC
3
FDA Grants Fast Track Status to LYT-200 Combo in High-Risk MDS
4
FDA Approves Imlunestrant Plus Abemaciclib in ESR1-Mutated Breast Cancer
5